Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compassionate Use of Domperidone for Refractory Gastroparesis
NCT04699591Recruiting
- Start
- Apr 2013
- Primary completion
- Dec 2035
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of domperidone in gastroesophageal reflux disease (GERD), gastroparesis and gastrointestinal motility disorder. Primary endpoint: Change in disease severity up to 1 year. Started Apr 2013; status: recruiting.
02
Drugs
domperidone
03
Conditions
gastroesophageal reflux disease (GERD)gastroparesisgastrointestinal motility disorder
Beyond the preview
Go deeper on NCT04699591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04699591.